MOVING SCIENCE FORWARD
MultiPark is a strategic research area funded by the Swedish Government. Building on the strong tradition of cutting-edge research on Parkinson's and Alzheimer's diseases at Lund University, our vision is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases, in order to improve the quality of life for people living and ageing with these disorders.
Oskar Hansson, Associate Professor at the Department of Clinical Sciences in Malmö, has been named Wallenberg Clinical Fellow for 2015. The grant enables continued research for Oskar Hansson within the BioFINDER study, which aims to improve the diagnosis of dementia and Parkinson's disease, as well as unlocking the keys to understand the mechanisms behind these diseases.
Unwanted formation of blood vessels (angiogenesis) in the brain is likely to be the cause of intractable walking and balance difficulties for people who suffer from Parkinson’s disease. This conclusion is supported by new research from MultiPark researchers.
Oskar Hanson, researcher and Vice Coordinator at MultiPark, studies the mechanisms behind Alzheimer's disease: what are the causes of the main symptoms, and how can we at an early stage determine if bad memory is due to the onset of Alzheimer's disease? For this, he is now awarded 100,000 SEK by the Eric K. Fernström Foundation.
A few weeks ago MultiPark was informed by the Vice-Chancellor’s office that the government will keep the same funding in place for 2016 as it has been for 2015. With input from external board members, the steering group and the translational working groups, a budget is being prepared for the coming year.